Clinical trials: Hypercalciuria

Type 1 Diabetes Mellitus, Hypercalciuria

Safety and Efficacy of Chlorthalidone in Type 1 Diabetes

• Terminated
• Age: 12 to 21 years
• Phase 2
• Results posted

This open-label study will determine if chlorthalidone is safe and effective for the use of reducing urinary calcium excretion over 4 weeks in subjects with type 1 diabetes

Trial name

NCT03325114

Testing

Chlorthalidone

Where

United States

Volunteers

1 people

Sponsor

University of Rochester